home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

The role of natural products in drug discovery and development in the new millennium

 
  July 07, 2009  
     
 
Royal Pharmaceutical Society of Great Britain, London
Friday 4 December 2009


09.30 Registration and coffee

09.55 Opening comments by the Chair
Deniz Tasdemir, University of London, UK

10.00 Back to the future: the continuing value of natural products for drug discovery
Alan Harvey, University of Strathclyde, UK

10.30 In silico strategies for lead identification from Nature
Hermann Stuppner, University of Innsbruck, Austria

11.00 Streamlining the biodiscovery pipeline
Marcel Jaspars, University of Aberdeen, UK

11.30 Bioactive low molecular weight carbohydrate analogues
Robert Nash, Phytoquest Limited, UK

12.00 Lunch

13.00 Synthetic processes of marine anticancer drugs: PharmaMar’s experience
Carmen Cuevas, PharmaMar, Spain

13.30 Biosynthetic engineering approaches to natural product lead optimization
Barrie Wilkinson, Biotica Tech. Ltd, UK

14.00 A sustainable supply of artemisinin from Artemisia annua
Dianna J. Bowles, University of York, UK

14.30 Coffee

15.00 Panel discussion: The present and the future of natural products - where are we heading?
Chair: Deniz Tasdemir, Panel: all speakers

16.00 Close of conference

 
 
Organized by: Royal Pharmaceutical Society of Great Britain
Invited Speakers: please see programme
 
Deadline for Abstracts: N/a
 
Registration: 09.30
E-mail: events@rpsgb.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.